急性胰腺炎临床评分系统的研究进展  

Advances in clinical scoring system for acute pancreatit

作　　者：萨日那 梁鲁[2] 姚碧辉[2] 黄原[2] SA Rina;LIANG Lu;YAO Bihui;HUANG Yuan(Baotou Clinical Medial College,Inner Mongolia Medical University,Baotou 014040,China;Second Department of General Surgery,Baotou Central Hospital,Baotou 014040,China)

机构地区：[1]内蒙古医科大学包头临床医学院,内蒙古包头014040 [2]内蒙古包头市中心医院普外二科,内蒙古包头014040

出　　处：《山东第一医科大学（山东省医学科学院）学报》2023年第2期156-160,共5页Journal of Shandong First Medical University ＆ Shandong Academy of Medical Sciences

摘　　要：急性胰腺炎(acute pancreatitis,AP)是由多种病因引起胰酶异常激活导致自身炎症反应的消化系统疾病。轻症急性胰腺炎(mild acute pancreatitis,MAP)通过规范治疗可康复,而重症急性胰腺炎(severe acute pancreatitis,SAP)病情凶险,并发症多,死亡率高,故早期严重程度评价、病情进展评估具有重要意义。上世纪70年代,AP临床评价系统就已建立,为进一步提升对评分系统的认识,本文通过分析相关文献对临床中常用的评价方法进行综述。Acute pancreatitis(AP)is a digestive disease caused by abnormal activation of pancreatic enzymes leading to autoinflammation.Mild AP can be recovered by standardized treatment,while severe AP is dangerous,with many complications and high mortality.Therefore,early severity assessment and disease progression assessment play an important role in it.The clinical evaluation system for AP has been established since the 1970s.In order to further improve the understanding of the scoring system,this paper describes and discusses the commonly used evaluation methods in clinical practice,which are described in the paper.

关 键 词：急性胰腺炎 临床评分系统 研究进展 

分 类 号：R576[医药卫生—消化系统]